Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maintenance Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07225270
What this trial is testing

Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy

Who this might be right for
Ovarian CancerPlatinum-sensitive Ovarian CancerPSOC
Genmab 544
Testing effectiveness (Phase 2)Looking for participantsNCT05460000
What this trial is testing

A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+1 more
North Eastern German Society of Gynaecological Oncology 640
Large-scale testing (Phase 3)WithdrawnNCT00090675
What this trial is testing

Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
AstraZeneca
Large-scale testing (Phase 3)Study completedNCT01596933
What this trial is testing

Effect of Omega-3 Supplements on the Prevention of Cachexia in Head and Neck Cancer Treated With Radio(Chemo)Therapy

Who this might be right for
Cancer CachexiaHead and Neck Cancer
General Hospital Groeninge 91
Large-scale testing (Phase 3)Ended earlyNCT02004184
What this trial is testing

Pemetrexed in Advanced Non-Small-Cell Lung Cancer: at Progression vs Maintenance Therapy After Induction Chemotherapy

Who this might be right for
Carcinoma, Non-small-cell Lung
Norwegian University of Science and Technology 230
Testing effectiveness (Phase 2)Looking for participantsNCT06418087
What this trial is testing

Durvalumab With Carboplatin and Etoposide Chemotherapy in Pulmonary Large-cell Neuroendocrine Carcinoma (LCNEC)

Who this might be right for
Pulmonary Large-cell Neuroendocrine Carcinoma
Gruppo Oncologico Italiano di Ricerca Clinica 49
Testing effectiveness (Phase 2)Study completedNCT03759587
What this trial is testing

Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Takeda 19
Large-scale testing (Phase 3)Study completedNCT01034163
What this trial is testing

A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL)

Who this might be right for
Hodgkin's Lymphoma
Novartis Pharmaceuticals 41
Not applicableActive Not RecruitingNCT06484114
What this trial is testing

Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide

Who this might be right for
ObesityWeight Change TrajectoryWeight Change, Body
Fractyl Health Inc. 315
Large-scale testing (Phase 3)Study completedNCT00022516
What this trial is testing

Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 1,086
Large-scale testing (Phase 3)Ended earlyNCT03516084
What this trial is testing

Niraparib as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Zai Lab (Shanghai) Co., Ltd. 185
Early research (Phase 1)WithdrawnNCT05228249
What this trial is testing

Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements+7 more
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00205764
What this trial is testing

Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy

Who this might be right for
Multiple Myeloma
Austrian Forum Against Cancer 212
Post-approval studies (Phase 4)Study completedNCT00042146
What this trial is testing

Behavioral and Pharmacological Treatment for Insomnia

Who this might be right for
Sleep Initiation and Maintenance Disorders
Laval University 160
Testing effectiveness (Phase 2)Study completedNCT03793361
What this trial is testing

Phase II Study of Regorafenib as Maintenance Therapy

Who this might be right for
Metastatic Soft Tissue Sarcoma
Centre Oscar Lambret 127
Not applicableUnknownNCT02188693
What this trial is testing

Gemcitabine as a Single Agent in the Maintenance Chemotherapy of Patients With Metastatic Breast Cancer

Who this might be right for
Stage IIIB, IV, Recurrent, and Metastatic Breast CancerGemcitabineMaintenance Chemotherapy
Xijing Hospital 267
Testing effectiveness (Phase 2)Study completedNCT00001084
What this trial is testing

Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT06232564
What this trial is testing

Etoposide-carboplatin in Combination With Pembrolizumab and Lenvatinib Maintenance in HG-NETs

Who this might be right for
Neuroendocrine Tumors
Imperial College London 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT06779318
What this trial is testing

Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/Metastasis

Who this might be right for
Pancreatic CancerPostoperative Adjuvant TherapyMaintenance Therapy
The First Affiliated Hospital with Nanjing Medical University 464
Testing effectiveness (Phase 2)WithdrawnNCT00004040
What this trial is testing

Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell Neoplasm
Hoag Memorial Hospital Presbyterian
Next Page